In Other News

• IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy

• New Library Normalization and Amplification Tools Support Oncology Sequencing

• Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging

• Statistical Method Improves Detection of Low-Level Cancer DNA in Blood Samples

• Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring

• Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing

• AI Tool Improves Accuracy of Cancer Liquid Biopsy for Therapy Selection

• TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy

• Study Highlights Inherited Breast Cancer Risk Genes in Young Black Women

• Targeted RNA Test Enhances Genetic Diagnosis in Exome Sequencing

• AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides

• Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer

• Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures

• Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency

• Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

• New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs

• Automated Blood Culture System Speeds Detection of Bloodstream Infections

• New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

• Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

• 3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer

• AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead